March 7, 2012—Four influential members of Congress have asked Safety Net Hospitals for Pharmaceutical Access (SNHPA), Apexus, Inc., which operates the 340B Prime Vendor Program (PVP), Pharmaceutical Research and Manufacturers of America (PhRMA), and the Biotechnology Industry Organization (BIO) for a wide range of documents about their involvement in the 340B program.
The March 5 letters were sent by Sens. Charles Grassley of Iowa, ranking Republican on the Judiciary Committee; Michael Enzi of Wyoming, ranking Republican on the Health, Education, Labor and Pensions Committee; Orrin Hatch, ranking Republican on the Finance Committee; and Rep. Joe Pitts (R-PA), the chairman of the Energy and Commerce Subcommittee on Health.
You must be registered to read complete articles (it's quick, easy, and 100% free). Click here to register. Already registered? Click here to login. (340B Health members, Drug Discount Monitor subscribers, and 340B Coalition conference attendees: Use your existing username and password.)